Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple Mieloma”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Not applicableNot Yet RecruitingNCT07564128
What this trial is testing

Infection Surveillance of R/R Multiple Myeloma Patients Treated With Elranatamab as Clinical Practice in Italy

Who this might be right for
Multiple Mieloma
Gruppo Italiano Malattie EMatologiche dell'Adulto 50
Testing effectiveness (Phase 2)UnknownNCT00804947
What this trial is testing

Autologous Stem Cell Transplant (ASCT) With Intravenous Busulfan and Melphalan as Conditioning Regimen

Who this might be right for
Multiple Myeloma
Fundacion Para La Investigacion Hospital La Fe 50
Not applicableStudy completedNCT06782854
What this trial is testing

Understanding the Role of Large Extracellular Vesicles in Lymphomas and Lymphoproliferative Disorders: the "Off the Beaten Track" Liquid Biopsy

Who this might be right for
Diffuse Large B-Cell LymphomaFollicular LymphomaMarginal Zone Lymphoma(MZL)+5 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 102
Not applicableStudy completedNCT06810115
What this trial is testing

Respiatory Viral Infections in Patients With Multiple Myeloma

Who this might be right for
Multiple MielomaRespiratory Viral Infections
University Medical Centre Ljubljana 219
Not applicableLooking for participantsNCT06874530
What this trial is testing

Efficacy of Isatuximab-based Regimens in Relapsed/Refractory Multiple Myeloma With 1q21+

Who this might be right for
Multiple Mieloma
IRCCS Azienda Ospedaliero-Universitaria di Bologna 30
Testing effectiveness (Phase 2)UnknownNCT00702247
What this trial is testing

Tandem Autologous- Nonmyeloablative Allogeneic Transplant for Newly Diagnosed Multiple Myeloma (Trapianto Tandem Autologo-Allogenico Non Mieloablativo Nel Mieloma Alla Diagnosi)

Who this might be right for
Multiple Myeloma
Azienda Ospedaliera San Giovanni Battista
Testing effectiveness (Phase 2)UnknownNCT01325896
What this trial is testing

Maintenance Treatment of Multiple Myeloma (MM) After Autologous Peripheral Blood Transplant (PBSCT) Using Polyethylene Glycol alpha2B Interpheron (PEG-INTRON)

Who this might be right for
Multiple Mieloma
Fundación de Investigación Biomédica - Hospital Universitario de La Princesa 33
Not applicableLooking for participantsNCT07777406
What this trial is testing

Real-life Study on the Use of Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Relapsed/Refractory Multiple Myeloma

Who this might be right for
Plasma Cell Neoplasms
Università degli Studi 'G. d'Annunzio' Chieti e Pescara 60
Not applicableLooking for participantsNCT06795815
What this trial is testing

The Implementation of the Go Wish Game to Promote Advance Care Planning in Onco- Hematologic Disease

Who this might be right for
LeukemiaMultiple MielomaAdvanced Solid Tumors+3 more
Azienda USL Reggio Emilia - IRCCS 75
Not applicableStudy completedNCT07611812
What this trial is testing

Real-World Patterns of Utilization of Lenalidomide-based Triplet Regimens in FIrst RElapsed Multiple Myeloma Patients: Evidence From Medical Record Review

Who this might be right for
Multiple MielomaFirst RelpaseRd-base Triplet
Fondazione IRCCS Policlinico San Matteo di Pavia 100